[1]
Tronieri, J.S. et al. 2022. WEIGHT LOSS WITH LIRAGLUTIDE 3.0 mg VERSUS PLACEBO FOR INDIVIDUALS WHO ADHERE TO THE TRIAL DRUG: A SECONDARY ANALYSIS FROM SCALE IBT. Journal of the ASEAN Federation of Endocrine Societies. 34, 2 (Jun. 2022), 46–47.